Milgamma Protekt, 90

Vitamin preparation for the treatment of neuropathies and cardiovascular disorders caused by vitamin B1 deficiency.

Important information (mandatory information):

Milgamma® protekt. Active ingredient: benfotiamine. Areas of application: Treatment of neuropathies and cardiovascular disorders caused by vitamin B1 deficiency. Therapy or prophylaxis of clinical vitamin B1 deficiency, if these cannot be remedied nutritionally.

Read the information leaflet about risks and side effects and ask your doctor or pharmacist.

Product features:

What is Milgamma® Protekt and what is it used for?
Milgamma® protekt is a vitamin preparation.

Field of use:
Secure areas of application for the monopreparations are exclusively therapy or prophylaxis of clinical vitamin B1 deficiency states, provided that these cannot be remedied with nutrition.

The clinically proven vitamin B1 deficiency can occur in:
Malnutrition and malnutrition (e.g. beriberi), long-term parenteral nutrition, zero diet, hemodialysis, malabsorption, chronic alcoholism (alcohol-toxic cardiomyopathy, Wernicke encephalopathy, Korsakow syndrome), increased need (e.g. pregnancy and lactation).

Treatment of neuropathies and cardiovascular disorders caused by vitamin B1 deficiency.

How to take Milgamma® Protekt
Always take milgamma® protekt exactly as described in this package insert or exactly as agreed with the doctor or pharmacist.
Please ask your doctor or pharmacist if you are not sure.

The following information applies unless your doctor has prescribed milgamma® protekt otherwise. Please adhere to the dosage instructions, otherwise milgamma® protekt cannot work properly!

The recommended dose is 1 film-coated tablet once a day.

The film-coated tablets are swallowed whole with some liquid. For the therapy of neuropathies, milgamma® protekt mitial should be taken over a period of at least 3 weeks. Subsequent treatment follows according to therapeutic success.

Duration of application:
The duration of taking milgamma® protekt depends on the therapeutic success. If after four weeks there is no or too little effect, the therapy of the symptoms should be checked.
Please talk to your doctor or pharmacist if you have the impression that the effects of milgamma® protekt are too strong or too weak.

How to store Milgamma® Protekt
Store drug out of reach of children.

Do not use the medicine after the expiry date which is stated on the carton after ‘EXP’. The expiry date refers to the last day of the month.